EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Comparative survival outcomes of surgical resection versus radiotherapy after FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer

Jiwon Yu, Jeong Ha Lee, Hyunju Shin, Hee Chul Park, Joon Oh Park, Jung Yong Hong, Minsuk Kwon, Ji Eun Shin, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park und 7 weitere

Precision and Future Medicine · 31.03.2026 · 10 (1) · 39-50

DOI: 10.23838/pfm.2026.00037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision and Future Medicine, erschienen am 31.03.2026. Verfasst von Jiwon Yu und 18 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluated the clinical outcomes and prognostic factors in patients with borderline resectable pancreatic cancer (BRPC) and locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX followed by local-regional therapy (LRT), surgical resection (SR), and radiotherapy (RT). We aimed to identify specific patient subgroups for which RT may serve as a reasonable alternative to SR for local tumor control.

Methods

We retrospectively analyzed 116 patients (SR group, n= 70; RT group, n= 46) at a single center between 2015 and 2020. Survival outcomes were compared based on LRT modalities, focusing on identifying subgroups in which RT provided an efficacy comparable to that of SR.

Results

Among 116 patients, the SR group achieved a significantly higher 5-year overall survival (OS) than the RT group (27.1% vs. 8.7%, P< 0.0001), despite similar progression-free survival (P= 0.23). Significant prognostic factors for OS included carbohydrate antigen 19-9 (CA19-9) response in BRPC (P= 0.02) and radiologic partial response in LAPC (P= 0.05). Subgroup analysis revealed that, while SR provided a survival advantage in CA19-9 responders, no significant difference in OS was observed between SR and RT in CA19-9 non-responders (P= 0.37).

Conclusion

Although surgery remains the gold standard, RT may be considered a justifiable local alternative for CA19-9 non-responders and surgically ineligible patients with LAPC, yielding comparable outcomes in these specific, biologically unfavorable subgroups.

Förderung

  • National Research Foundation of Korea
  • Ministry of Science and ICT

Zitieren

APA

Yu, J., Lee, J. H., Shin, H., Park, H. C., Park, J. O., Hong, J. Y., Kwon, M., Shin, J. E., Lee, K. T., Lee, K. H., Lee, J. K., Park, J. K., Choi, Y. H., Heo, J. S., Han, I. W., Shin, S. H., Kim, H., Min, J. H., & Yu, J. I. (2026). Comparative survival outcomes of surgical resection versus radiotherapy after FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer. Precision and Future Medicine, 10(1), 39-50. https://doi.org/10.23838/pfm.2026.00037

Vancouver

Yu J, Lee JH, Shin H, Park HC, Park JO, Hong JY, et al. Comparative survival outcomes of surgical resection versus radiotherapy after FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer. Precision and Future Medicine. 2026;10(1):39-50. doi:10.23838/pfm.2026.00037

BibTeX
@article{Yu2026,
  author = {Yu, Jiwon and Lee, Jeong Ha and Shin, Hyunju and Park, Hee Chul and Park, Joon Oh and Hong, Jung Yong and Kwon, Minsuk and Shin, Ji Eun and Lee, Kyu Taek and Lee, Kwang Hyuck and Lee, Jong Kyun and Park, Joo Kyung and Choi, Young Hoon and Heo, Jin Seok and Han, In Woong and Shin, Sang Hyun and Kim, Hongbeom and Min, Ji Hye and Yu, Jeong Il},
  title = {Comparative survival outcomes of surgical resection versus radiotherapy after FOLFIRINOX in borderline resectable and locally advanced pancreatic cancer},
  journal = {Precision and Future Medicine},
  year = {2026},
  volume = {10},
  number = {1},
  pages = {39--50},
  doi = {10.23838/pfm.2026.00037}
}
Kostenlos starten →